These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7406385)

  • 1. Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression.
    Schimpff SC
    Ann Intern Med; 1980 Aug; 93(2):358-61. PubMed ID: 7406385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.
    Guiot HF; van Furth R
    Infection; 1984; 12(1):1-4. PubMed ID: 6423548
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia.
    Hargadon MT; Young VM; Schimpff SC; Wade JC; Minah GE
    Antimicrob Agents Chemother; 1981 Nov; 20(5):620-4. PubMed ID: 6275778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
    Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
    J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriologic management of patients with decreased resistance].
    Hendriks WD; Sizoo W; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1984 Feb; 128(7):305-10. PubMed ID: 6422314
    [No Abstract]   [Full Text] [Related]  

  • 8. Infections in cancer patients: some controversial issues.
    Schimpff SC; Scott DA; Wade JC
    Support Care Cancer; 1994 Mar; 2(2):94-104. PubMed ID: 8156272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gram-negative bacteremia.
    Schimpff SC
    Support Care Cancer; 1993 Jan; 1(1):5-18. PubMed ID: 8143100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse isolation and decontamination in children with defect of immune capacities and a decrease of colonization resistance.
    Vossen JM; van der Waay D; Dooren LJ
    Padiatr Padol; 1972; 7(2):120-3. PubMed ID: 4636440
    [No Abstract]   [Full Text] [Related]  

  • 12. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
    Otis LL; Terezhalmy GT
    Oral Surg Oral Med Oral Pathol; 1985 Jul; 60(1):125-9. PubMed ID: 3162130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
    Dekker AW; Rozenberg-Arska M; Verhoef J
    Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perils of prophylaxis.
    Jacoby GA
    N Engl J Med; 1982 Jan; 306(1):43-4. PubMed ID: 7053471
    [No Abstract]   [Full Text] [Related]  

  • 16. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
    de Jongh CA; Wade JC; Finley RS; Joshi JH; Aisner J; Wiernik PH; Schimpff SC
    J Clin Oncol; 1983 May; 1(5):302-7. PubMed ID: 6321684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures.
    Guiot HF; Helmig-Schurter AV; van der Meer JW; van Furth R
    Scand J Infect Dis; 1986; 18(2):153-60. PubMed ID: 3704563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.
    Schimpff SC; Greene WH; Young VM; Fortner CL; Cusack N; Block JB; Wiernik PH
    Ann Intern Med; 1975 Mar; 82(3):351-8. PubMed ID: 1054222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopenia.
    Martino P; Venditti M; Petti MC; Mandelli F; Serra P
    Am J Med Sci; 1984; 287(3):7-9. PubMed ID: 6375370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
    Dekker AW; Rozenberg-Arska M; Sixma JJ; Verhoef J
    Ann Intern Med; 1981 Nov; 95(5):555-9. PubMed ID: 6794406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.